{{Rsnum
|rsid=6671200
|Gene=NUP210P3
|Chromosome=1
|position=95231973
|Orientation=plus
|GMAF=0.0831
|Gene_s=NUP210P3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.9 | 11.6 | 87.5
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.9 | 99.1
| YRI | 4.1 | 25.9 | 70.1
| ASW | 3.5 | 24.6 | 71.9
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 3.6 | 30.0 | 66.4
| MEX | 0.0 | 15.8 | 84.2
| MKK | 3.8 | 33.3 | 62.8
| TSI | 1.0 | 14.7 | 84.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23362303
  |Trait=Stearic acid (18:0) plasma levels
  |Title=Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
  |RiskAllele=A
  |Pval=2E-15
  |OR=.25
  |ORtxt=unit decrease
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}